
GNE-987 is a highly active chimeric BET degrader. GNE-987 exhibits picomolar клетка BRD4 degradation activity (DC50=0.03 nM for EOL-1 AML клетка line). GNE-987 binds equipotently to the BD1 and BD2 bromodomains of BRD4 with low nanomolar affinities (IC50=4.7 and 4.4 nM, respectively). GNE-987 incorporates a мощный BET binder/ингибитор, a VHL-связывание fragment, and a ten methylene spacer moiety. GNE-987 can be used in PROTAC-антитело Conjugate (PAC).
GNE-987 is a highly active chimeric BET degrader. GNE-987 exhibits picomolar cell BRD4 degradation activity (DC50=0.03 nM for EOL-1 AML cell line). GNE-987 binds equipotently to the BD1 and BD2 bromodomains of BRD4 with low nanomolar affinities (IC50=4.7 and 4.4 nM, respectively). GNE-987 incorporates a potent BET binder/inhibitor, a VHL-binding fragment, and a ten methylene spacer moiety. GNE-987 can be used in PROTAC-Antibody Conjugate (PAC).
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.